Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 3, 2005, Pages 213-222

  Antin, Joseph H ^a   Guinan, Eva C ^a   Avigan, David ^b   Soiffer, Robert J ^a   Joyce, Robin M ^b   Martin, Victoria J ^c   Molrine, Deborah C ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Autologous; Hematopoietic cell transplantation; Immunization; Pneumococcal conjugate vaccine

Indexed keywords

BUSULFAN; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; IFOSFAMIDE; IMMUNOGLOBULIN G ANTIBODY; PCV 7; PNEUMOCOCCUS VACCINE; THIOTEPA;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARM DISEASE; ARM MOVEMENT; ARTHRALGIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CHILD; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG DOSE REGIMEN; EDEMA; ERYTHEMA; FEMALE; FEVER; HEADACHE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION PAIN; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; MALAISE; MALE; RANDOMIZED CONTROLLED TRIAL; REVACCINATION; SEROTYPE; STEM CELL MOBILIZATION; STREPTOCOCCUS PNEUMONIA;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNIZATION; MALE; MIDDLE AGED; PAIN; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; TRANSPLANTATION, AUTOLOGOUS; VACCINES, CONJUGATE;

EID: 14244256477     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2004.12.330     Document Type: Article

References (36)

1. S. Kulkarni R. Powles J. Treleaven et al. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants Blood 95 2000 3683-3686
2. D. Engelhard C. Cordonnier P.J. Shaw et al. Early and late invasive pneumococcal infection following stem cell transplantation: A European Bone Marrow Transplantation survey Br J Haematol 117 2002 444-460
3. C.A. Sable G.R. Donowitz Infections in bone marrow transplant recipients Clin Infect Dis 18 1994 273-284
4. C. Hoyle J.M. Goldman Life-threatening infections occurring more than 3 months after BMT Bone Marrow Transplant 14 1994 247-252
5. L.G. Lum The kinetics of immune reconstitution after human marrow transplantation Blood 69 1987 368-380
6. S. Kiesel A. Pezzutto G. Moldenhauer et al. B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation Blood 72 1988 672-678
7. R.A. Miller J. Daley R. Ghalie H. Kaizer Clonal analysis of T-cell deficiencies in autotransplant recipients Blood 77 1991 1845-1850
8. V. Hammarstrom K. Pauksen B. Bjorkstrand B. Simonsson G. Oberg P. Ljungman Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients Bone Marrow Transplant 22 1998 67-71
9. Centers for Disease Control and Prevention Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation MMWR Recomm Rep 49 RR-10 2000 9-10
10. D.J. Winston W.G. Ho G. Schiffman R.E. Champlin S.A. Feig R.P. Gale Pneumococcal vaccination of recipients of bone marrow transplants Arch Intern Med 143 1983 1735-1737
11. E.C. Guinan D.C. Molrine J.H. Antin et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients Transplantation 57 1994 677-684
12. M.A. Avanzini A.M. Carra R. Maccario et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation J Clin Immunol 15 1995 137-144
13. V. Spoulou P. Victoratos J. Ioannidis S. Grafakos Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants J Infect Dis 182 2000 965-969
14. R.A. Insel P.W. Anderson Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants J Exp Med 163 1986 262-269
15. J. Eskola Immunogenicity of pneumococcal conjugate vaccines Pediatr Infect Dis J 19 2000 388-393
16. S.B. Black H.R. Shinefield B. Fireman et al. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 children Pediatr Infect Dis J 10 1991 97-104
17. M. Santosham M. Wolfe R. Reid et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex N Engl J Med 324 1991 1767-1772
18. S. Black H. Shinefield B. Fireman et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Pediatr Infect Dis J 19 2000 187-195
19. D.C. Molrine E.C. Guinan J.H. Antin et al. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation Blood 87 1996 3012-3018
20. A. Barra C. Cordonnier M.P. Preziosi et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients J Infect Dis 166 1992 1021-1028
21. D.C. Molrine J.H. Antin E.C. Guinan et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation Blood 101 2003 831-836
22. L. Jodar J. Butler G. Carlone et al. Serological criteria for evaluation and licensure of new pneumococcal conjugate formulations for use in infants Vaccine 21 2003 3265-3272
23. Consultative meeting on WHO guidelines for production and quality control of pneumococcal conjugate vaccines, Geneva,2003,June 4-5. Available: http://www.who.int/biologicals/ Pneumococcal_Conjugate_Vaccines_Recomm_Nov_2003.pdf
24. D.C. Molrine E.C. Guinan J.H. Antin et al. Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation Bone Marrow Transplant 17 1996 1149-1155
25. G.R. Siber Pneumococcal disease: Prospects for a new generation of vaccines Science 265 1994 1385-1387
26. P.H. Henon H. Liang G. Beck-Wirth et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants Bone Marrow Transplant 9 1992 285-291
27. L.B. To M.M. Roberts D.N. Haylock et al. Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplant, autologous bone marrow transplant and allogeneic home marrow transplants Bone Marrow Transplant 9 1992 277-284
28. C.Y. Chan D.C. Molrine J.H. Antin et al. Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT) Bone Marrow Transplant 20 1997 33-38
29. M.K. Gandhi W. Egner L. Sizer et al. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients Bone Marrow Transplant 28 2001 775-781
30. T. Nordoy A. Husebekk I.S. Aaberge et al. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccination according to EBMT guidelines Bone Marrow Transplant 28 2001 681-687
31. E. Vance S. George E.C. Guinan et al. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation Bone Marrow Transplant 22 1998 735-741
32. L. Pan J. Delmonte C.K. Jalonen J.L.M. Ferrara Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduced severity of experimental graft-versus-host-diseases Blood 86 1995 4422-4429
33. P. Anderlini D. Przepiorka R. Champlin M. Korbling Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals Blood 88 1996 2819-2825
34. A. Hata H. Asanuma M. Rinki et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants N Engl J Med 347 2002 26-34
35. T.A. Davis F.J. Hsu C.B. Caspar et al. Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma Biol Blood Marrow Transplant 7 2001 517-522
36. S. Arai H.G. Klingemann Role of immunotherapy in stem cell transplantation Int J Hematol 77 2003 22-28